Royal Philips partners with NYU Langone Health

Royal Philips, the parent company of Philips, is entering an eight-year strategic partnership with NYU Langone Health valued at $115 million.

With this new partnership, NYU Langone Health will adopt Philips’ IntelliSite Pathology software, enterprise informatics, and AI-enabled diagnostic imaging technologies such as the Philips Lumify Handheld Ultrasound. NYU Langone will also use the Philips Patient Information Center iX and the Philips Capsule Medical Device Information Platform to simplify workflows.

The two organizations are also developing new research programs initially focused on a roadmap for the future of digital pathology, patient monitoring, ultrasound, and MRI.

Page 1 of 505
Next Page